Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

BACKGROUND: Currently accepted therapies for ragweed allergy in North America consist of pharmacotherapy and subcutaneous allergen immunotherapy injections to treat symptoms. Allergen immunotherapy not only reduces symptoms and the need for pharmacotherapy but has also been shown to have disease-mod...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Allergy Asthma Clin Immunol
Main Authors: Kim, Harold, Waserman, Susan, Hébert, Jacques, Blaiss, Michael, Nelson, Harold, Creticos, Peter, Kaur, Amarjot, Maloney, Jennifer, Li, Ziliang, Nolte, Hendrik
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363352/
https://ncbi.nlm.nih.gov/pubmed/25788949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-10-55
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados